US 12275940
Conjugated antisense compounds and their use
granted A61KA61K31/713A61K47/554
Quick answer
US patent 12275940 (Conjugated antisense compounds and their use) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/713, A61K47/554, A61K9/0085